127 related articles for article (PubMed ID: 25377256)
1. Bone marrow cellular cannibalism by medulloblastoma.
Escamilla V; Franco-Macías E; Calderón-Cabrera C; Rivas E; Morales-Camacho RM; Vargas MT; Bernal R; Pérez-Simón JA
Am J Hematol; 2015 May; 90(5):466-7. PubMed ID: 25377256
[No Abstract] [Full Text] [Related]
2. [Reliability of molecular tumour markers in children with medulloblastoma--an example from clinical practice].
Pfister S
Z Evid Fortbild Qual Gesundhwes; 2011; 105(7):511-3. PubMed ID: 21958611
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell phagocytosis. Its occurrence in a patient with medulloblastoma.
Youness E; Barlogie B; Ahearn M; Trujillo JM
Arch Pathol Lab Med; 1980 Dec; 104(12):651-3. PubMed ID: 6893661
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow relapse of medulloblastoma mimicking acute leukemia with translocation (1;18)(p33;q22).
Lou Y; Meng H; Mao L; Jin J
J Clin Oncol; 2011 Jan; 29(2):e24-6. PubMed ID: 20940187
[No Abstract] [Full Text] [Related]
5. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma in two brothers.
Yamashita Y; Handa H; Toyama M
Surg Neurol; 1975 Aug; 4(2):225-7. PubMed ID: 1162594
[TBL] [Abstract][Full Text] [Related]
7. Clinico-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations.
López GY; Grant GA; Fuchs HE; Leithe LG; Gururangan S; Bigner DD; Yan H; McLendon RE; He Y
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):217-20. PubMed ID: 23659599
[No Abstract] [Full Text] [Related]
8. Large-cell medulloblastoma with arrestin-like protein expression.
Vincent S; Mirshari M; Nicolas C; Adenis C; Dhellemmes P; Soto Ares G; Maurage CA; Baranzelli MC; Giangaspero F; Ruchoux MM
Clin Neuropathol; 2003; 22(1):1-9. PubMed ID: 12617187
[TBL] [Abstract][Full Text] [Related]
9. Clinical Aggressiveness of TP53-Wild Type Sonic Hedgehog Medulloblastoma With MYCN Amplification, Chromosome 17p Loss, and Chromothripsis.
Mitani Y; Fukuoka K; Mori M; Arakawa Y; Matsushita Y; Hibiya Y; Honda S; Kobayashi M; Tanami Y; Kanemura Y; Ichimura K; Nakazawa A; Kurihara J; Koh K
J Neuropathol Exp Neurol; 2021 Jan; 80(2):205-207. PubMed ID: 33367701
[No Abstract] [Full Text] [Related]
10. Hedgehogs, flies, Wnts and MYCs: the time has come for many things in medulloblastoma.
Monje M; Beachy PA; Fisher PG
J Clin Oncol; 2011 Apr; 29(11):1395-8. PubMed ID: 21357776
[No Abstract] [Full Text] [Related]
11. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
Rutkowski S; von Bueren A; von Hoff K; Hartmann W; Shalaby T; Deinlein F; Warmuth-Metz M; Soerensen N; Emser A; Bode U; Mittler U; Urban C; Benesch M; Kortmann RD; Schlegel PG; Kuehl J; Pietsch T; Grotzer M
Clin Cancer Res; 2007 May; 13(9):2651-7. PubMed ID: 17473196
[TBL] [Abstract][Full Text] [Related]
12. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth.
Hatton BA; Knoepfler PS; Kenney AM; Rowitch DH; de Alborán IM; Olson JM; Eisenman RN
Cancer Res; 2006 Sep; 66(17):8655-61. PubMed ID: 16951180
[TBL] [Abstract][Full Text] [Related]
13. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
[TBL] [Abstract][Full Text] [Related]
14. [Medulloblastoma and spino-meningeal metastaszing. Differential diagnosis in the clinical picture and pathologic anatomy. A case contribution].
Thörner G; Schuier F
Nervenarzt; 1976 Jun; 47(6):392-7. PubMed ID: 958540
[No Abstract] [Full Text] [Related]
15. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.
Zhou L; Picard D; Ra YS; Li M; Northcott PA; Hu Y; Stearns D; Hawkins C; Taylor MD; Rutka J; Der SD; Huang A
Cancer Res; 2010 Oct; 70(20):8199-210. PubMed ID: 20876797
[TBL] [Abstract][Full Text] [Related]
16. Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.
Hill RM; Kuijper S; Lindsey JC; Petrie K; Schwalbe EC; Barker K; Boult JK; Williamson D; Ahmad Z; Hallsworth A; Ryan SL; Poon E; Robinson SP; Ruddle R; Raynaud FI; Howell L; Kwok C; Joshi A; Nicholson SL; Crosier S; Ellison DW; Wharton SB; Robson K; Michalski A; Hargrave D; Jacques TS; Pizer B; Bailey S; Swartling FJ; Weiss WA; Chesler L; Clifford SC
Cancer Cell; 2015 Jan; 27(1):72-84. PubMed ID: 25533335
[TBL] [Abstract][Full Text] [Related]
17. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
[TBL] [Abstract][Full Text] [Related]
18. TP53 Mutation, MYCN Amplification, and Large Cell/Anaplastic Histology in Medulloblastoma.
Das A; Zameer L; Vinarkar S; Singh M; Parihar M; Arora N; Chandra A; Achari RB
Indian J Pediatr; 2018 Aug; 85(8):684-685. PubMed ID: 29139064
[No Abstract] [Full Text] [Related]
19. c-myc overexpression causes anaplasia in medulloblastoma.
Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
[TBL] [Abstract][Full Text] [Related]
20. Elevated c-myc expression in childhood medulloblastomas.
MacGregor DN; Ziff EB
Pediatr Res; 1990 Jul; 28(1):63-8. PubMed ID: 2198527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
